REPORTS

Let’s Pullulate and Expand Your Business

Oligonucleotides Market - Global Professional Analysis and Forecast to 2026

Jan 01, 2020  |  201 PAGES  |  REPORT CODE: CMM259213
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The worldwide Oligonucleotides market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period.

This report presents the market size and development trends by detailing the Oligonucleotides market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Oligonucleotides market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Oligonucleotides industry and will help you to build a panoramic view of the industrial development.

Oligonucleotides Market, By Type:

  • DNA Oligomers

  • RNA Oligomers

Oligonucleotides Market, By Application:

  • Genetic Testing

  • Research

  • Forensics

  • Others

Some of the leading players are as follows:

  • AltaBioscience

  • Eton Bioscience Inc

  • Life biotech

  • Biolegio

  • AM Chemicals

  • ThermoFisher

  • SGS DNA

  • AM Biotechnologies LLC

  • Eurofins Genomics

  • Beijing SBS Genetech

  • Sigma-Aldrich

  • Ella Biotech

  • Creative Biogene

  • Bioneer

  • Oligo Factory

  • Bio Basic

  • TriLink BioTechnologies

  • Syntezza Bioscience

  • BGI

  • Biomatik

  • Microsynth AG

  • Exiqon

  • IDT

  • TAG Copenhagen

  • DNA Services Core

Geographically, Major regions are analyzed in details are as follows:

  • North America

  • Europe

  • Asia Pacific

  • Latin America

  • Middle East & Africa

Table of Contents

1 Methodology and Scope

  • 1.1 Market Segmentation & Scope

    • 1.1.1 Technology Type

    • 1.1.2 Product

    • 1.1.3 Application

    • 1.1.4 Regional scope

    • 1.1.5 Estimates and forecast timeline

  • 1.2 Research Methodology

  • 1.3 Information Procurement

    • 1.3.1 Purchased database

    • 1.3.2 Internal database

    • 1.3.3 Secondary sources

    • 1.3.4 Primary research

    • 1.3.5 Details of primary research

  • 1.4 Information or Data Analysis

    • 1.4.1 Data analysis models

  • 1.5 Market Formulation & Validation

  • 1.6 Model Details

    • 1.6.1 Commodity flow analysis

    • 1.6.2 Volume price analysis

  • 1.7 List of Secondary Sources

  • 1.8 List of Abbreviations

2 Executive Summary

  • 2.1 Market Outlook

  • 2.2 Segment Outlook

3 Market Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook

  • 3.1.1 Parent market outlook

    • 3.1.2 Ancillary market outlook

  • 3.2 Market Segmentation

    • 3.2.1 Analysis

  • 3.3 Market Dynamics

    • 3.3.1 Market driver analysis

    • 3.3.2 Market restraint analysis

    • 3.3.3 Industry opportunities

  • 3.4 Penetration & Growth Prospect Mapping

    • 3.4.1 Penetration & growth prospect mapping analysis

  • 3.5 Business Environment Analysis Tools

    • 3.5.1 Porter's five forces analysis

    • 3.5.2 PESTLE analysis

    • 3.5.3 Major deals & strategic alliances analysis

4 Oligonucleotides Market: Technology Type Analysis

  • 4.1 Oligonucleotides Technology Type Market Share Analysis, 2018 & 2026

  • 4.2 Oligonucleotides Technology Type Market: Segment Dashboard

  • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

    • 4.3.1 DNA Oligomers

    • 4.3.2 RNA Oligomers

5 Oligonucleotides Market: Product Analysis

  • 5.1 Oligonucleotides Product Market Share Analysis, 2018 & 2026

  • 5.2 Oligonucleotides Product Market: Segment Dashboard

  • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

6 Oligonucleotides Market: Application Analysis

  • 6.1 Oligonucleotides Application Market Share Analysis, 2018 & 2026

  • 6.2 Oligonucleotides Application Market: Segment Dashboard

  • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

    • 6.3.1 Genetic Testing

    • 6.3.2 Research

    • 6.3.3 Forensics

    • 6.3.4 Others

7 Oligonucleotides Market: Regional Analysis

  • 7.1 Oligonucleotides Regional Market Share Analysis, 2018 & 2026

  • 7.2 Oligonucleotides Regional Market: Segment Dashboard

  • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

  • 7.4 List of Players at Regional Level

    • 7.4.1 North America

    • 7.4.2 Europe

    • 7.4.3 Asia Pacific

  • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

    • 7.5.1 North America

    • 7.5.2 Europe

    • 7.5.3 Asia Pacific

    • 7.5.4 Latin America

    • 7.5.5 MEA

  • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

    • 7.6.1 North America

    • 7.6.2 Europe

    • 7.6.3 Asia Pacific

    • 7.6.4 Latin America

    • 7.6.5 Middle East & Africa

8 Competitive Analysis

  • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

  • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

  • 8.3 Vendor Landscape

    • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

9 Company Profiles

  • 9.1 AltaBioscience

    • 9.1.1 AltaBioscience Company overview

    • 9.1.2 Financial performance

    • 9.1.3 Product benchmarking

    • 9.1.4 Strategic initiatives

    • 9.1.5 SWOT analysis

  • 9.2 Eton Bioscience Inc

    • 9.2.1 Eton Bioscience Inc Company overview

    • 9.2.2 Financial performance

    • 9.2.3 Product benchmarking

    • 9.2.4 Strategic initiatives

    • 9.2.5 SWOT analysis

  • 9.3 Life biotech

    • 9.3.1 Life biotech Company overview

    • 9.3.2 Financial performance

    • 9.3.3 Product benchmarking

    • 9.3.4 Strategic initiatives

    • 9.3.5 SWOT analysis

  • 9.4 Biolegio

    • 9.4.1 Biolegio Company overview

    • 9.4.2 Financial performance

    • 9.4.3 Product benchmarking

    • 9.4.4 Strategic initiatives

    • 9.4.5 SWOT analysis

  • 9.5 AM Chemicals

    • 9.5.1 AM Chemicals Company overview

    • 9.5.2 Financial performance

    • 9.5.3 Product benchmarking

    • 9.5.4 Strategic initiatives

    • 9.5.5 SWOT analysis

  • 9.6 ThermoFisher

    • 9.6.1 ThermoFisher Company overview

    • 9.6.2 Financial performance

    • 9.6.3 Product benchmarking

    • 9.6.4 Strategic initiatives

    • 9.6.5 SWOT analysis

  • 9.7 SGS DNA

    • 9.7.1 SGS DNA Company overview

    • 9.7.2 Financial performance

    • 9.7.3 Product benchmarking

    • 9.7.4 Strategic initiatives

    • 9.7.5 SWOT analysis

  • 9.8 AM Biotechnologies LLC

    • 9.8.1 AM Biotechnologies LLC Company overview

    • 9.8.2 Financial performance

    • 9.8.3 Product benchmarking

    • 9.8.4 Strategic initiatives

    • 9.8.5 SWOT analysis

  • 9.9 Eurofins Genomics

    • 9.9.1 Eurofins Genomics Company overview

    • 9.9.2 Financial performance

    • 9.9.3 Product benchmarking

    • 9.9.4 Strategic initiatives

    • 9.9.5 SWOT analysis

  • 9.10 Beijing SBS Genetech

    • 9.10.1 Beijing SBS Genetech Company overview

    • 9.10.2 Financial performance

    • 9.10.3 Product benchmarking

    • 9.10.4 Strategic initiatives

    • 9.10.5 SWOT analysis

  • 9.11 Sigma-Aldrich

    • 9.11.1 Sigma-Aldrich Company overview

    • 9.11.2 Financial performance

    • 9.11.3 Product benchmarking

    • 9.11.4 Strategic initiatives

    • 9.11.5 SWOT analysis

  • 9.12 Ella Biotech

    • 9.12.1 Ella Biotech Company overview

    • 9.12.2 Financial performance

    • 9.12.3 Product benchmarking

    • 9.12.4 Strategic initiatives

    • 9.12.5 SWOT analysis

  • 9.13 Creative Biogene

    • 9.13.1 Creative Biogene Company overview

    • 9.13.2 Financial performance

    • 9.13.3 Product benchmarking

    • 9.13.4 Strategic initiatives

    • 9.13.5 SWOT analysis

  • 9.14 Bioneer

    • 9.14.1 Bioneer Company overview

    • 9.14.2 Financial performance

    • 9.14.3 Product benchmarking

    • 9.14.4 Strategic initiatives

    • 9.14.5 SWOT analysis

  • 9.15 Oligo Factory

    • 9.15.1 Oligo Factory Company overview

    • 9.15.2 Financial performance

    • 9.15.3 Product benchmarking

    • 9.15.4 Strategic initiatives

    • 9.15.5 SWOT analysis

  • 9.16 Bio Basic

    • 9.16.1 Bio Basic Company overview

    • 9.16.2 Financial performance

    • 9.16.3 Product benchmarking

    • 9.16.4 Strategic initiatives

    • 9.16.5 SWOT analysis

  • 9.17 TriLink BioTechnologies

    • 9.17.1 TriLink BioTechnologies Company overview

    • 9.17.2 Financial performance

    • 9.17.3 Product benchmarking

    • 9.17.4 Strategic initiatives

    • 9.17.5 SWOT analysis

  • 9.18 Syntezza Bioscience

    • 9.18.1 Syntezza Bioscience Company overview

    • 9.18.2 Financial performance

    • 9.18.3 Product benchmarking

    • 9.18.4 Strategic initiatives

    • 9.18.5 SWOT analysis

  • 9.19 BGI

    • 9.19.1 BGI Company overview

    • 9.19.2 Financial performance

    • 9.19.3 Product benchmarking

    • 9.19.4 Strategic initiatives

    • 9.19.5 SWOT analysis

  • 9.20 Biomatik

    • 9.20.1 Biomatik Company overview

    • 9.20.2 Financial performance

    • 9.20.3 Product benchmarking

    • 9.20.4 Strategic initiatives

    • 9.20.5 SWOT analysis

  • 9.21 Microsynth AG

    • 9.21.1 Microsynth AG Company overview

    • 9.21.2 Financial performance

    • 9.21.3 Product benchmarking

    • 9.21.4 Strategic initiatives

    • 9.21.5 SWOT analysis

  • 9.22 Exiqon

    • 9.22.1 Exiqon Company overview

    • 9.22.2 Financial performance

    • 9.22.3 Product benchmarking

    • 9.22.4 Strategic initiatives

    • 9.22.5 SWOT analysis

  • 9.23 IDT

    • 9.23.1 IDT Company overview

    • 9.23.2 Financial performance

    • 9.23.3 Product benchmarking

    • 9.23.4 Strategic initiatives

    • 9.23.5 SWOT analysis

  • 9.24 TAG Copenhagen

    • 9.24.1 TAG Copenhagen Company overview

    • 9.24.2 Financial performance

    • 9.24.3 Product benchmarking

    • 9.24.4 Strategic initiatives

    • 9.24.5 SWOT analysis

  • 9.25 DNA Services Core

    • 9.25.1 DNA Services Core Company overview

    • 9.25.2 Financial performance

    • 9.25.3 Product benchmarking

    • 9.25.4 Strategic initiatives

    • 9.25.5 SWOT analysis

 

The List of Tables and Figures (Totals 106 Figures and 150 Tables)

  • Figure DNA Oligomers Oligonucleotides market, 2015 - 2026 (USD Million)

  • Figure RNA Oligomers Oligonucleotides market, 2015 - 2026 (USD Million)

  • Figure Genetic Testing market, 2015 - 2026 (USD Million)

  • Figure Research market, 2015 - 2026 (USD Million)

  • Figure Forensics market, 2015 - 2026 (USD Million)

  • Figure Others market, 2015 - 2026 (USD Million)

  • Table List of players in North America

  • Table List of players in Europe

  • Table List of players in Asia Pacific

  • Table SWOT analysis

  • Table North America Oligonucleotides market, by country, 2015 - 2026 (USD Million)

  • Table North America Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table North America Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table North America Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.S. Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table U.S. Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table U.S. Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Canada Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Canada Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Canada Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Europe Oligonucleotides market, by country, 2015 - 2026 (USD Million)

  • Table Europe Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Europe Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Europe Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table U.K. Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table U.K. Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table U.K. Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Germany Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Germany Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Germany Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table France Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table France Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table France Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Italy Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Italy Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Italy Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Spain Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Spain Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Spain Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Asia Pacific Oligonucleotides market, by country, 2015 - 2026 (USD Million)

  • Table Asia Pacific Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Asia Pacific Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Asia Pacific Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table China Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table China Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table China Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Japan Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Japan Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Japan Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table India Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table India Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table India Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Latin America Oligonucleotides market, by country, 2015 - 2026 (USD Million)

  • Table Latin America Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Latin America Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Latin America Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Brazil Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Brazil Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Brazil Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Mexico Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Mexico Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Mexico Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Argentina Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Argentina Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Argentina Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table MEA Oligonucleotides market, by country, 2015 - 2026 (USD Million)

  • Table MEA Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table MEA Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table MEA Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table South Africa Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table South Africa Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table South Africa Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Regulatory scenario

  • Table Nigeria Oligonucleotides market, by type, 2015 - 2026 (USD Million)

  • Table Nigeria Oligonucleotides market, by product, 2015 - 2026 (USD Million)

  • Table Nigeria Oligonucleotides market, by application, 2015 - 2026 (USD Million)

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Recent Developments & Impact Analysis, by Key Market Participants

  • Table Company market position analysis

  • Table Company Profiles

  • Table AltaBioscience Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eton Bioscience Inc Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Life biotech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biolegio Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AM Chemicals Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table ThermoFisher Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table SGS DNA Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table AM Biotechnologies LLC Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Eurofins Genomics Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Beijing SBS Genetech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Sigma-Aldrich Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Ella Biotech Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Creative Biogene Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bioneer Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Oligo Factory Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Bio Basic Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table TriLink BioTechnologies Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Syntezza Bioscience Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table BGI Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Biomatik Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Microsynth AG Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table Exiqon Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table IDT Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table TAG Copenhagen Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

  • Table Company Profiles

  • Table DNA Services Core Production, Value, Price, Gross Margin 2014-2019

  • Table Product benchmarking

  • Table Strategic initiatives

  • Table SWOT analysis

Report Purchase

reports
$3850
$7700
BUY NOWClick MeBUY NOW
top